Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation

[1]  F. Gao,et al.  A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program , 2015, Acta Diabetologica.

[2]  F. Hu,et al.  Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism , 2014, Cardiovascular Diabetology.

[3]  A. Tenenbaum,et al.  Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? , 2014, Cardiovascular Diabetology.

[4]  F. Farzadfar,et al.  Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy , 2014, Journal of Diabetes & Metabolic Disorders.

[5]  T. Funahashi,et al.  Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity , 2013, Cardiovascular Diabetology.

[6]  Y. Matsuzawa,et al.  Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes , 2013, Journal of diabetes investigation.

[7]  C. Takayama,et al.  Brown Rice and Its Component, γ-Oryzanol, Attenuate the Preference for High-Fat Diet by Decreasing Hypothalamic Endoplasmic Reticulum Stress in Mice , 2012, Diabetes.

[8]  T. Funahashi,et al.  Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes , 2012, Cardiovascular Diabetology.

[9]  T. Funahashi,et al.  Metabolic syndrome correlates with polyvascular lesions detected by systemic vascular ultrasonography in Japanese people with type 2 diabetes. , 2012, Diabetes research and clinical practice.

[10]  T. Funahashi,et al.  Cardio Vascular Diabetology O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[11]  T. Funahashi,et al.  Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes. , 2011, Atherosclerosis.

[12]  T. Wong,et al.  Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. , 2011, Investigative ophthalmology & visual science.

[13]  P. Whincup,et al.  High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[14]  S. Kihara,et al.  Increment and impairment of adiponectin in renal failure. , 2010, Cardiovascular research.

[15]  C. Snehalatha,et al.  Diabetes in Asia , 2010, The Lancet.

[16]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[18]  H. Kaneto,et al.  Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. , 2009, Atherosclerosis.

[19]  Margarita D. Tsiros,et al.  Cognitive behavioral therapy improves diet and body composition in overweight and obese adolescents. , 2008, The American journal of clinical nutrition.

[20]  岡内 幸義.  Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men , 2008 .

[21]  P Zimmet,et al.  Ethnic comparisons of the cross‐sectional relationships between measures of body size with diabetes and hypertension , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[22]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[23]  Ho-Young Son,et al.  Epidemic obesity and type 2 diabetes in Asia , 2006, The Lancet.

[24]  Makoto Nishida,et al.  A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. , 2005, Diabetes care.

[25]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[26]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[27]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.

[28]  R. Roubenoff,et al.  Eating behavior correlates of adult weight gain and obesity in healthy women aged 55-65 y. , 2002, The American journal of clinical nutrition.

[29]  Y. Akanuma,et al.  Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. , 2001, Diabetes research and clinical practice.

[30]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[31]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[32]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[33]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[34]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[35]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[36]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[37]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[38]  J. Després,et al.  Effects of Diet and Physical Activity on Adiposity and Body Fat Distribution: Implications for the Prevention of Cardiovascular Disease , 1993, Nutrition Research Reviews.

[39]  E. Buskirk,et al.  Ventilatory response of moderately obese women to submaximal exercise. , 1991, International journal of obesity.

[40]  T. Funahashi,et al.  Relationships between circulating adiponectin levels and fat distribution in obese subjects. , 2011, Journal of atherosclerosis and thrombosis.

[41]  P. Barnes,et al.  Epidemiology, Risk Factors and Pathophysiology , 2011 .

[42]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[43]  E. Oda.  New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[44]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[45]  Eiji Oda,et al.  New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[46]  Y. Matsuzawa,et al.  Treatment of visceral fat obesity. , 1991, International journal of obesity.

[47]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.